Integrated Diagnostics Holdings annual shareholders’ equity
2021
2022
2023
2024
2025
Integrated Diagnostics Holdings Shareholders’ Equity Growth & History (IDHC)
Integrated Diagnostics Holdings's shareholders’ equity was E£3.38B for fiscal 2025.
View full Integrated Diagnostics Holdings company overviewIntegrated Diagnostics Holdings annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | E£3.38B | E£673.0M | +24.83% |
| 2024 | 2024-12-31 | E£2.71B | E£31.2M | +1.17% |
| 2023 | 2023-12-31 | E£2.68B | E£524.8M | +24.36% |
| 2022 | 2022-12-31 | E£2.15B | −E£428.8M | −16.60% |
| 2021 | 2021-12-31 | E£2.58B | — | — |
Integrated Diagnostics Holdings shareholders’ equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Integrated Diagnostics Holdings's shareholders’ equity increased from E£2.58B to E£3.38B, a change of E£800.3M.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Integrated Diagnostics Holdings source filings ↗